<?xml version="1.0" encoding="UTF-8"?>
<p>It currently takes approximately a decade and $2.6 billion for one drug to proceed from initial testing in humans to licencing (
 <xref rid="fcaa031-B24" ref-type="bibr">DiMasi 
  <italic>et al.</italic>, 2016
 </xref>), and âˆ¼90% of drugs in Phase I clinical trials are never launched, mostly due to insufficient efficacy and safety (
 <xref rid="fcaa031-B41" ref-type="bibr">Harrison, 2016</xref>; 
 <xref rid="fcaa031-B84" ref-type="bibr">Smietana 
  <italic>et al.</italic>, 2016
 </xref>).
</p>
